GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 112 participants.
Also called NCT06827990
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT06827990
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06827990. Non-randomized; no masking; primary purpose treatment. Start 2025-09-22 (actual); primary completion 2030-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
- Acronym
- ARISE III
- Condition
- Aortic Dissection
- Intervention (Device)
- GORE® Ascending Stent Graft (ASG device)
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct06827990- Content hash
265f6cf3fd97b65c34470cc84aac7f5e325a4a0153849a83b3aba16065bfee9b